Matches in SemOpenAlex for { <https://semopenalex.org/work/W3212755013> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W3212755013 endingPage "915" @default.
- W3212755013 startingPage "905" @default.
- W3212755013 abstract "Depression, a neurological disorder, is globally the 4th leading cause of chronic disabilities in human beings.This study aimed to model a 2D-QSAR equation that can facilitate the researchers to design better aplysinopsin analogs with potent hMAO-A inhibition.Aplysinopsin analogs dataset were subjected to ADME assessment for drug-likeness suitability using StarDrop software before modeled equation. 2D-QSAR equations were generated using VLife MDS 4.6. Dataset was segregated into training and test set using different methodologies, followed by variable selection. Model development was done using principal component regression, partial least square regression, and multiple regression.The dataset has successfully qualified the drug-likeness criteria in ADME simulation, with more than 90% of molecules cleared the ideal conditions, including intrinsic solubility, hydrophobicity, CYP3A4 2C9pKi, hERG pIC50, etc. 112 models were developed using multiparametric consideration of methodologies. The best six models were discussed with their extent of significance and prediction capabilities. ALP97 was emerged out as the most significant model out of all, with ~83% of the variance in the training set, the internal predictive ability of ~74%, while having the external predictive capability of ~79%.ADME assessment suggested that aplysinopsin analogs are worth investigating. Interaction among the descriptors in the way of summation or multiplication products are quite influential and yield significant 2D-QSAR models with good prediction efficiency. This model can be used to design a more potent hMAO-A inhibitor with an aplysinopsin scaffold, which can then contribute to the treatment of depression and other neurological disorders." @default.
- W3212755013 created "2021-11-22" @default.
- W3212755013 creator A5015689940 @default.
- W3212755013 creator A5027539618 @default.
- W3212755013 creator A5045977931 @default.
- W3212755013 creator A5081095213 @default.
- W3212755013 creator A5087708783 @default.
- W3212755013 date "2021-09-01" @default.
- W3212755013 modified "2023-09-23" @default.
- W3212755013 title "Physicochemical, Interaction & Topological Descriptors vs. hMAO-A Inhibition of Aplysinopsin Analogs: A Boulevard to the Discovery of Semi-Synthetic Anti-Depression Agents" @default.
- W3212755013 doi "https://doi.org/10.2174/1389200222666211015155014" @default.
- W3212755013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34779368" @default.
- W3212755013 hasPublicationYear "2021" @default.
- W3212755013 type Work @default.
- W3212755013 sameAs 3212755013 @default.
- W3212755013 citedByCount "1" @default.
- W3212755013 countsByYear W32127550132023 @default.
- W3212755013 crossrefType "journal-article" @default.
- W3212755013 hasAuthorship W3212755013A5015689940 @default.
- W3212755013 hasAuthorship W3212755013A5027539618 @default.
- W3212755013 hasAuthorship W3212755013A5045977931 @default.
- W3212755013 hasAuthorship W3212755013A5081095213 @default.
- W3212755013 hasAuthorship W3212755013A5087708783 @default.
- W3212755013 hasConcept C119857082 @default.
- W3212755013 hasConcept C124101348 @default.
- W3212755013 hasConcept C127413603 @default.
- W3212755013 hasConcept C152877465 @default.
- W3212755013 hasConcept C154945302 @default.
- W3212755013 hasConcept C164126121 @default.
- W3212755013 hasConcept C183696295 @default.
- W3212755013 hasConcept C2780035454 @default.
- W3212755013 hasConcept C33923547 @default.
- W3212755013 hasConcept C41008148 @default.
- W3212755013 hasConcept C69366308 @default.
- W3212755013 hasConcept C70721500 @default.
- W3212755013 hasConcept C86803240 @default.
- W3212755013 hasConcept C98274493 @default.
- W3212755013 hasConceptScore W3212755013C119857082 @default.
- W3212755013 hasConceptScore W3212755013C124101348 @default.
- W3212755013 hasConceptScore W3212755013C127413603 @default.
- W3212755013 hasConceptScore W3212755013C152877465 @default.
- W3212755013 hasConceptScore W3212755013C154945302 @default.
- W3212755013 hasConceptScore W3212755013C164126121 @default.
- W3212755013 hasConceptScore W3212755013C183696295 @default.
- W3212755013 hasConceptScore W3212755013C2780035454 @default.
- W3212755013 hasConceptScore W3212755013C33923547 @default.
- W3212755013 hasConceptScore W3212755013C41008148 @default.
- W3212755013 hasConceptScore W3212755013C69366308 @default.
- W3212755013 hasConceptScore W3212755013C70721500 @default.
- W3212755013 hasConceptScore W3212755013C86803240 @default.
- W3212755013 hasConceptScore W3212755013C98274493 @default.
- W3212755013 hasFunder F4320321001 @default.
- W3212755013 hasFunder F4320322322 @default.
- W3212755013 hasFunder F4320336042 @default.
- W3212755013 hasIssue "11" @default.
- W3212755013 hasLocation W32127550131 @default.
- W3212755013 hasLocation W32127550132 @default.
- W3212755013 hasOpenAccess W3212755013 @default.
- W3212755013 hasPrimaryLocation W32127550131 @default.
- W3212755013 hasRelatedWork W2024788260 @default.
- W3212755013 hasRelatedWork W2046645906 @default.
- W3212755013 hasRelatedWork W2047065195 @default.
- W3212755013 hasRelatedWork W2258518595 @default.
- W3212755013 hasRelatedWork W2519019522 @default.
- W3212755013 hasRelatedWork W2606973919 @default.
- W3212755013 hasRelatedWork W2905607758 @default.
- W3212755013 hasRelatedWork W2977422675 @default.
- W3212755013 hasRelatedWork W3117501106 @default.
- W3212755013 hasRelatedWork W4306911903 @default.
- W3212755013 hasVolume "22" @default.
- W3212755013 isParatext "false" @default.
- W3212755013 isRetracted "false" @default.
- W3212755013 magId "3212755013" @default.
- W3212755013 workType "article" @default.